Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-14

Clinical Trial Update: Raclopride-PET/MRT [NA]

View source ↗

Summary

The clinical trial using Raclopride-PET/MRT for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raclopride-PET/MRT radiotracer (Raclopride)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED